Harrison Rosemary 4
4 · TCR2 THERAPEUTICS INC. · Filed Dec 19, 2022
Insider Transaction Report
Form 4
Harrison Rosemary
Chief Business & Strategy
Transactions
- Award
Stock Option (Right to Buy)
2022-12-15+76,930→ 76,930 totalExercise: $0.97Exp: 2032-12-14→ Common Stock (76,930 underlying) - Award
Restricted Stock Unit (Right to Buy)
2022-12-15+12,822→ 12,822 total→ Common Stock (12,822 underlying)
Footnotes (3)
- [F1]25% of this option shall vest and become exercisable on the one-year anniversary of the date of grant, with the remainder vesting in thirty-six (36) equal monthly installments thereafter.
- [F2]Each restricted stock unit represents a right to receive one share of the issuer's common stock at the time of vesting for no consideration.
- [F3]The restricted stock units will vest 25% on the one-year anniversary of the date of grant, with the remainder vesting in three equal annual installments thereafter.